KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Accumulated Expenses: 2017-2024

Historic Accumulated Expenses for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $177.0 million.

  • Elanco Animal Health's Accumulated Expenses rose 12.74% to $177.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $177.0 million, marking a year-over-year increase of 12.74%. This contributed to the annual value of $177.0 million for FY2024, which is 12.74% up from last year.
  • Per Elanco Animal Health's latest filing, its Accumulated Expenses stood at $177.0 million for FY2024, which was up 12.74% from $157.0 million recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Accumulated Expenses registered a high of $185.0 million during FY2021, and its lowest value of $144.0 million during FY2020.
  • For the 3-year period, Elanco Animal Health's Accumulated Expenses averaged around $160.0 million, with its median value being $157.0 million (2023).
  • As far as peak fluctuations go, Elanco Animal Health's Accumulated Expenses soared by 44.58% in 2020, and later dropped by 21.08% in 2022.
  • Yearly analysis of 5 years shows Elanco Animal Health's Accumulated Expenses stood at $144.0 million in 2020, then grew by 28.47% to $185.0 million in 2021, then declined by 21.08% to $146.0 million in 2022, then climbed by 7.53% to $157.0 million in 2023, then rose by 12.74% to $177.0 million in 2024.